Panchsheel Organics Limited has published the extract of its audited financial results for the quarter and year ended March 31, 2026, in newspapers on June 1, 2026. The results were previously approved by the Board of Directors during its meeting held on May 30, 2026. The company operates in a single reportable segment, the manufacturing and trading of bulk drugs and intermediates, with total assets reported at ₹17,193.14 lakh as of March 31, 2026.

For the financial year ended March 31, 2026, the company reported a net profit of ₹1,083.04 lakh, a decrease from ₹1,379.45 lakh in the previous year. Revenue from operations for FY26 stood at ₹10,678.26 lakh, compared to ₹10,717.8 lakh in FY25. The board recommended a final dividend of ₹0.80 per share for the financial year, subject to shareholder approval at the ensuing Annual General Meeting. The record date for determining eligibility has been fixed as Friday, June 12, 2026.

Key Financial Metrics for FY26

For the quarter ended March 31, 2026, the company recorded a net profit of ₹170.22 lakh, compared to ₹317.11 lakh in the corresponding period of the previous year. Revenue from operations for Q4FY26 was ₹3,107.14 lakh. M/s. Jayesh R. Shah & Co., Chartered Accountants, the statutory auditors, issued an unmodified opinion on the financial results.

The board approved related party transactions for the year 2026-27 through omnibus approval and appointed M/s. Talati and Associates as the cost auditor for the financial year 2026-27. The trading window for designated persons remains closed until 48 hours after the declaration of the audited financial results.

Panchsheel Organics Limited has submitted its compliance certificate under Regulation 74(5) of Securities and Exchange Board of India (Depositories and Participants) Regulations, 2018 for the quarter and financial year ended March 31, 2026. The certificate was filed with BSE Limited on April 09, 2026, through the company's registrar and share transfer agent, Purva Sharegistry (I) Pvt. Ltd.

Regulatory Compliance Confirmation

The certificate confirms that all securities received from depository participants for dematerialisation during the quarter ended March 2026 were properly processed and confirmed to the depositories. Purva Sharegistry, acting as the compliance officer, verified that all security certificates received for dematerialisation were confirmed or rejected within the prescribed timelines.

Dematerialisation Activity Details

During the period from January 01, 2026 to March 31, 2026, the company processed five dematerialisation transactions involving a total of 1,900 shares:

Process Verification

The registrar confirmed that all security certificates received were properly mutilated and cancelled after due verification by the depository participant. The names of the depositories have been substituted in the register of members as the registered owner within the prescribed timelines, ensuring compliance with SEBI regulations.

Company Information

Panchsheel Organics Limited, a manufacturer of bulk drugs and formulations, operates from its corporate office in Andheri East, Mumbai. The company's Managing Director, Mahendra Abhaychand Turakhia, signed the compliance submission to BSE Limited. The certificate demonstrates the company's adherence to regulatory requirements for share dematerialisation processes during the quarter.